Biden's new COVID-19 panel includes ex-Surgeon General Vivek Murthy, Trump whistleblower Rick Bright

President-elect Joe Biden announced Sunday that his COVID-19 "transition advisory board" would be led by former Surgeon General Dr. Vivek Murthy and Dr. David Kessler, a former FDA commissioner. He will meet with the new task force on Monday.
The other dozen high-profile doctors on the task force, Politico reports, include Atul Gawande, a former Health and Humans Services official and New Yorker writer; Rick Bright, the vaccine expert who testified against President Trump after being ousted as head of the Biomedical Advanced Research and Development Authority; University of Minnesota infectious disease specialist Michael Osterholm; former FDA chief scientist and Trump National Security Council member Luciana Borio; Zeke Emanuel; Yale's Marcella Nunez-Smith, NYU's Celine Grounder; Eric Goosby and Robert Rodriguez at UC San Francisco; Julie Morita of the Robert Wood Johnson Foundation; and Loyce Pace of the Global Health Council.
The U.S. just surpassed 10 million COVID-19 cases and is averaging more than 100,000 cases and 1,000 deaths a day. Public health experts warn there could be another 100,000 deaths before Biden is inaugurated Jan. 20. The task force will turn Biden's campaign proposals for tackling the coronavirus into a governing blueprint, including free testing, hiring contact tracers, and providing clear guidance. Public health experts hope the new president can enact a national response to the pandemic and clarify months of mixed messaging from Trump and his administration.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
US foodies brace for tariff war
Under The Radar Shoppers stocking up on imported olive oil, maple syrup and European wine as price hikes loom
By Chas Newkey-Burden, The Week UK Published
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published